I am a computational biologist who currently studies cancer. Before I studied physics and mathematics at the Technion and the Weizmann Institute in Israel. And at some point, sequencing and genomics appeared and captured my interest as a data scientist.  So, during my Ph.D. at the Max Planck Institute in Berlin, I studied the genomes evolution of species but I wanted to understand how mutations happen in somatic tissues during the lifetime of cells. This led me to study cancer genomes. I studied what shapes somatic mutation rates along human chromosomes and with my colleagues we found that it is chromatin, transcription, and replication.

My lab is dedicated to eliminating cancer and improving health via genomics and data analysis. We study the etiology of cancer across understudied populations with the goal of lowering cancer-related deaths and impacting the success of immunotherapies across a wide range of cancer patients. I have been building genomic partnerships with international and national partners in order to investigate the etiology of cancer and responses to it among different populations.